Conditions: Extrahepatic Bile Duct Cancer; Gallbladder Cancer; Liver Cancer
Interventions: Drug: capecitabine; Drug: gemcitabine hydrochloride; Procedure: oral chemotherapy; Procedure: parenteral chemotherapy; Procedure: quality-of-life assessment
Sponsors: National Cancer Institute of Canada; National Cancer Institute (NCI)
Not yet recruiting - verified April 2008
By Cancer
3971 items (3971 unread) in 83 feeds
Click on blue folders to expand
Adrenal Gland Cancer
(438)
Ampulla Of Vater
(26)
Anal Cancer
(272)
Angiosarcoma
(69)
Appendix Cancer
(34)
Bile Duct Cancer
(525)
Brain & CNS
(753)
Carcinoid
(165)
Endocrine/Neuroendocrine
(256)
Gall Bladder Cancer
(88)
General
(109)
Hemangioendothelioma
(28)
HemeOnc
(443)
Hepatoblastoma
(61)
Pancreas
(48)
Phyllodes
(12)
Rhabdomyosarcoma
(214)
Sarcoma
(287)
Trial - Bile Duct Cancer (6 unread)
-
Gemcitabine With or Without Capecitabine in Treating Patients With Locally Advanced, Unresectable, or Metastatic Biliary Cancer
Posted: April 12th, 2008, 10:00am EDT
-
CBT-1 and Paclitaxel in Treating Patients With Refractory, Recurrent, or Advanced Metastatic Solid Tumors
Posted: April 12th, 2008, 10:00am EDT
Condition: Cancer
Interventions: Drug: MDR modulator CBT-1; Drug: paclitaxel; Drug: technetium 99m sestamibi; Procedure: chemosensitization/potentiation therapy; Procedure: drug resistance inhibition treatment; Procedure: parenteral chemotherapy; Procedure: radionuclide imaging
Sponsor: National Cancer Institute (NCI)
Recruiting - verified April 2008 -
Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Gastrointestinal Cancer
Posted: April 4th, 2008, 10:00am EDT
Conditions: Anal Cancer; Carcinoma of the Appendix; Colorectal Cancer; Esophageal Cancer; Extrahepatic Bile Duct Cancer; Gallbladder Cancer; Gastric Cancer; Gastrointestinal Carcinoid Tumor; Gastrointestinal Stromal Tumor; Liver Cancer; Pancreatic Cancer; Small Intestine Cancer
Interventions: Drug: fluorouracil; Drug: irinotecan hydrochloride; Drug: leucovorin calcium; Procedure: parenteral chemotherapy; Procedure: pharmacogenomic studies; Procedure: pharmacological study
Sponsors: Mayo Clinic; National Cancer Institute (NCI)
Not yet recruiting - verified April 2008 -
Randomized Controlled Trial on the Evaluation of Pylorus-Ring in Pancreaticoduodenectomy
Posted: March 14th, 2008, 10:00am EDT
Conditions: Pancreatic Cancer; Bile Duct Cancer; Ampullary Cancer; Duodenal Cancer; Pancreatitis
Interventions: Procedure: pylorus-preserving pancreaticoduodenectomy; Procedure: pylorus-resecting pancreaticoduodenectomy
Sponsor: Wakayama Medical University
Recruiting - verified March 2008 -
CO07204-Phase I/II of Oxaliplatin, Capecitabine & Sorafenib for Advanced Pancreatic & Biliary Carcinoma
Posted: March 5th, 2008, 10:00am EST
Conditions: Pancreatic Neoplasms; Bile Duct Neoplasms
Interventions: Drug: Oxaliplatin; Drug: Capecitabine; Drug: Sorafenib
Sponsors: University of Wisconsin, Madison; Bayer Health Care Pharmaceuticals; Sanofi-Aventis
Recruiting - verified March 2008 -
Gemcitabine With Peptide Vaccine Therapy in Treating Patients With Bile Duct Cancer
Posted: February 19th, 2008, 10:00am EST
Condition: Bile Duct Cancer
Intervention: Biological: Peptide vaccine for URLC10 and gemcitabine
Sponsors: Akita University Hospital; Human Genome Center, Institute of Medical Science, University of Tokyo
Recruiting - verified February 2008